Since 1967, Balchem Corporation (NASDAQ: BCPC) has developed and manufactured specialty ingredients for the nutrition, health, and food markets around the world. Together with our employees, customers, and shareholders, we are committed to delivering products that improve all aspects of life.

We welcome you to explore our Investor Relations portal, where you can get to know our goals and strategies to support your investment decision and increase long-term shareholder value.

BCPC close on 2021-04-09 : $121.27 +0.67 (+0.56%)

News, Events, Presentations

Current Financials: Updated: February 19th, 2021

• Record net sales of $180.7 million, an increase of $14.2 million, or 8.5%, compared to the prior year quarter. Year over year quarterly sales growth in all three segments, with record sales in Human Nutrition and Health and Animal Nutrition and Health.
• Record adjusted EBITDA was $43.6 million, an increase of $3.6 million, or 8.9%, from the prior year.
• GAAP net earnings were $22.2 million, an increase of $1.8 million, or 8.7% from the prior year. These net earnings resulted in GAAP earnings per share of $0.68.
• Adjusted net earnings of $26.9 million decreased $1.5 million or 5.4% from the prior year, resulting in adjusted earnings per share(a) of $0.83.
• The effective tax rate of 21.0% was 1,211 basis points higher than the prior year tax rate of 8.9%.
• Cash flows from operations were $48.0 million for the fourth quarter 2020, an increase of $15.0 million from the prior year, with quarterly free cash flow(a) of $35.0 million compared to $26.3 million for the prior year quarter.

Click here for the detailed Quarterly Report

Click here for the Q4 2020 Investor Presentation


Ted Harris

Chairman and Chief Executive Officer

Jim Hyde Bio

Jim Hyde

Senior Vice President and General Manager, Human Nutrition & Health

Martin Bengtsson

Chief Financial Officer

Jonathan Griffin

Vice President and General Manager, Animal Nutrition & Health

Mark Stach

General Counsel

Job van Gunsteren

Vice President and General Manager, Specialty Products

Board of Directors

Ted Harris

Chairman and Chief Executive Officer,
Balchem Corporation

John Televantos, PhD

Arsenal Capital Partners, Inc.

Perry W. Premdas

Former Chief Financial Officer,
Celanese AG.

Paul D. Coombs

Former EVP and Chief Operating Officer,
Tetra Technologies, Inc.

David B. Fischer

Former President and Chief Executive Officer,
Greif, Inc.

Joyce Lee

President, North America, Bayer Animal Health,

Matthew Wineinger

President and Chief Executive Officer,
United Sugars Corporation

Daniel E. Knutson

Former EVP and Chief Financial Officer,
Land O’Lakes

Let us know how we can help you. Contact